ARA-290 Laboratory Research Compound
ARA-290 is a synthetic research peptide derived from a non-erythropoietic fragment of erythropoietin (EPO). It was developed to support the study of tissue-protective and repair-related signaling pathways without activating red blood cell production. This targeted design allows researchers to examine cellular protection mechanisms under controlled laboratory conditions.
In research settings, ARA-290 is primarily studied for its selective interaction with the innate repair receptor (IRR). Through this pathway, researchers can analyze cellular responses to inflammatory signals, oxidative stress, and structural disruption while avoiding systemic hematopoietic effects. Its receptor specificity supports clearer data interpretation and consistent experimental outcomes.
The defined short-chain peptide structure of ARA-290 allows for reliable handling, accurate measurement, and reproducible performance across experimental protocols. These characteristics make it well suited for preclinical research models that require stability, precision, and repeatability over extended study periods.
Alpha Omega Peptide supplies ARA-290 in a research-grade format intended to meet the standards of professional laboratory environments. Each vial is prepared to support consistent experimental workflows while maintaining strict research-only compliance.
This compound is intended exclusively for laboratory research and analytical use. It is not designed for diagnostic, therapeutic, or consumptive applications.
- Compound Name: ARA-290
- Form: Lyophilized powder
- Purity: High purity (HPLC verified)
- Storage: Refrigerate after reconstitution; freeze at -20°C for long-term storage
- Intended Use: Research and laboratory analysis only
